Form 8-K - Current report:
SEC Accession No. 0001070081-25-000004
Filing Date
2025-01-03
Accepted
2025-01-03 16:27:37
Documents
14
Period of Report
2024-12-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20241231x8k.htm   iXBRL 8-K 42540
  Complete submission text file 0001070081-25-000004.txt   166281

Data Files

Seq Description Document Type Size
2 EX-101.SCH tmb-20241231.xsd EX-101.SCH 3972
3 EX-101.DEF tmb-20241231_def.xml EX-101.DEF 2803
4 EX-101.LAB tmb-20241231_lab.xml EX-101.LAB 16544
5 EX-101.PRE tmb-20241231_pre.xml EX-101.PRE 9652
16 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20241231x8k_htm.xml XML 4725
Mailing Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059
Business Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35969 | Film No.: 25506721
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)